Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Bellevue expects significantly lower Group net profit compared to prior year

2024 annual results
02.12.2024

Ad hoc announcement pursuant to Art. 53 of the SWX Listing Rules

  • No notable upturn in Bellevue’s targeted market segment of small- and mid-cap growth stocks within the healthcare sector
  • An 18% y-o-y decline in assets under management leads to a corresponding decline in earnings
  • Expenses related to workforce changes and organizational optimization and the move to Bellevue’s founding location in the city of Zurich represent an additional burden on reported earnings for 2024
  • Group net profit for the year is forecast to be 50-55% lower than the figure reported for 2023
  • Strong, equity-funded balance sheet remains a sound foundation

Based on the currently available internal figures,  Bellevue Group expects a  significantly lower Group net profit compared to 2023. Once again, there was no broad upturn yet in small- and mid-cap growth stocks within the healthcare sector – Bellevue’s acknowledged core investment expertise – although initial signs of a recovery were observed. The 18% year-on-year decline in average assets under management leads to lower earnings. Thanks to active cost management, a lasting reduction in operating expenses was achieved. However, Group results for the year will also be pressured by workforce changes and organizational optimization and by the move back to Bellevue’s founding location in the city of Zurich.

Consequently, Group net profit for 2024 is expected to be 50-55% lower compared to 2023. Bellevue continues to operate with a strong, equity-funded balance sheet.

The audited annual results for the 2024 financial year will be published on February 25, 2025.

 

Contact
Investor Relations
Stefano Montalbano, CFO Bellevue Group
Tel: +41 44 267 67 00, smn@bellevue.ch

Media Relations
Jürg Stähelin, IRF
Tel: +41 43 244 81 51, staehelin@irf-reputation.ch